brm421
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Feb 1, 2017 (NCT03066219)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- brm421
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07078955 | Phase 2 | Dec 31, 2025 | BRIM Biotechnology Inc. |
| NCT05695781 | Phase 3 | Feb 27, 2023 | BRIM Biotechnology Inc. |
| NCT04343287 | Phase 2/Phase 3 (Phase 3) | Jan 15, 2020 | BRIM Biotechnology Inc., ORA, Inc. |
| NCT03066219 | Phase 2 | Feb 1, 2017 | BRIM Biotechnology Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BRIM Biotechnology Inc. | For profit | 4 | 4 | 2 | 2017 |
| ORA, Inc. | For profit | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1